- Home
- FRSX vs DWTX Comparison
FRSX vs DWTX Comparison
Compare FRSX & DWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRSX
- DWTX
- Stock Information
- Founded
- FRSX N/A
- DWTX 2012
- Country
- FRSX Israel
- DWTX United States
- Employees
- FRSX N/A
- DWTX N/A
- Industry
- FRSX Computer Software: Prepackaged Software
- DWTX
- Sector
- FRSX Technology
- DWTX
- Exchange
- FRSX Nasdaq
- DWTX NYSE
- Market Cap
- FRSX 11.4M
- DWTX 10.1M
- IPO Year
- FRSX 2017
- DWTX N/A
- Fundamental
- Price
- FRSX $0.55
- DWTX $4.89
- Analyst Decision
- FRSX
- DWTX Strong Buy
- Analyst Count
- FRSX 0
- DWTX 1
- Target Price
- FRSX N/A
- DWTX $10.00
- AVG Volume (30 Days)
- FRSX 209.3K
- DWTX 107.9K
- Earning Date
- FRSX 06-17-2025
- DWTX 05-08-2025
- Dividend Yield
- FRSX N/A
- DWTX N/A
- EPS Growth
- FRSX N/A
- DWTX N/A
- EPS
- FRSX N/A
- DWTX N/A
- Revenue
- FRSX $436,000.00
- DWTX N/A
- Revenue This Year
- FRSX N/A
- DWTX N/A
- Revenue Next Year
- FRSX N/A
- DWTX N/A
- P/E Ratio
- FRSX N/A
- DWTX N/A
- Revenue Growth
- FRSX N/A
- DWTX N/A
- 52 Week Low
- FRSX $0.51
- DWTX $1.62
- 52 Week High
- FRSX $2.63
- DWTX $29.28
- Technical
- Relative Strength Index (RSI)
- FRSX 39.88
- DWTX N/A
- Support Level
- FRSX $0.53
- DWTX N/A
- Resistance Level
- FRSX $0.66
- DWTX N/A
- Average True Range (ATR)
- FRSX 0.03
- DWTX 0.00
- MACD
- FRSX -0.00
- DWTX 0.00
- Stochastic Oscillator
- FRSX 30.92
- DWTX 0.00
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.
About DWTX DOGWOOD THERAPEUTICS INC
Dogwood Therapeutics Inc, formerly Virios Therapeutics Inc, is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a virus-triggered abnormal immune response, such as fibromyalgia (FM) and long COVID (LC). Its product candidates include IMC-1 and IMC-2. IMC-1 is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.